Haley A. Losh
ORCID: 0000-0002-4412-6487Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 6 papers. Top paper: βAdvantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapyβ.
Garima Dixit, Yuping Zhang, Eric J. Devor, Haley A. Losh, A.M. Newtson +6 more
Garima Dixit, Yuping Zhang, Eric J. Devor, Haley A. Losh, A.M. Newtson +6 more
Yuping Zhang, Paige K. Malmrose, Haley A. Losh, A.M. Newtson, Eric J. Devor +3 more
A.M. Newtson, Eric J. Devor, Yuping Zhang, Paige K. Malmrose, Jianling Bi +13 more
Emily L. Symons, Lorenzo Buroni, Hiruni K. Sumanisiri, Jessica Andrew-Udoh, Emily Witt +7 more
Emily L. Symons, Lorenzo Buroni, Hiruni K. Sumanasiri, Jessica Andrew-Udoh, Emily Witt +7 more